ArticleFish physiology and biochemistry2025
Mitigating potential of Malva parviflora leaves against Polyram DF (dry flowable) toxicity in Nile tilapia: immune/apoptotic markers, biochemical, antioxidant, and histopathological insights.
Article in Fish physiology and biochemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally, the contamination of aquatic bodies by improper application of pesticides, particularly fungicides, endangered aquatic life and hampered sustainable aquaculture. Exploring innovative strategies to mitigate this difficult issue as eco-friendly and cost-effective is indispensable. Herein, the potential of dietary Egyptian mallow (Malva parviflora) leaves (EML) as a powder form to mitigate the toxicological implications of metiram (MET) exposure in Oreochromis niloticus (Nile tilapia) was assessed in this attempt. The investigation featured growth, physiological, immune/antioxidant responses, splenic cytokines expression, and histopathological concepts. In light of this, fish (N = 200; 32.80 ± 0.92 g) were eventually assigned into four groups with five sets (control, EML, MET, and EML + MET) for 63 days. The control and EML groups were given basal diets that had 0 and 15 g EML/kg diet, respectively, without MET exposure. Furthermore, MET and EML + MET groups were received the identical diets as control and EML groups, respectively, and exposed to 0.38 mg/L MET. The findings highlighted a significant (P < 0.001) growth retardation (declining in weight gain and specific growth rate) and higher fish mortality (32%) by MET exposure. Also, immune impairment (lowered immunoglobulin M and complement 3) and oxidative damage (higher malondialdehyde and declined catalase and superoxide dismutase) were the outcomes of MET toxicity. In addition, the biochemical biomarkers showed substantial disruptions (P < 0.001) in the MET group, where creatinine, aspartate aminotransferase, and alanine aminotransferase increased. Splenic expression of immune-relevant cytokines (interleukin-10 and interferon-gamma 1) was downregulated with upregulation of apoptosis (cysteine-aspartic acid protease-3) linked gene by MET toxicity (P < 0.001). Histologically, MET significantly provoked a diverse range of aberrations in the spleen, kidney, and liver tissues. Remarkably, feeding the EML diet to the MET group decreased fish mortality (14%) and refined all metrics, while retaining the histological integrity of tissues. The conclusion of this viewpoint recommends using dietary EML (15 g/kg) to diminish the deleterious effects of MET in toxicity in Nile tilapia to sustain aquaculture.
Indexed as
Identifiers
40377743What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.